PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2014

Protective effects of Hericium erinaceus mycelium and its isolated erinacine A against ischemia-injury-induced neuronal cell death via the inhibition of iNOS/p38 MAPK and nitrotyrosine.

Rat / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 25167134 ↗2014Reported benefit

Protective effects of Hericium erinaceus mycelium and its isolated erinacine A against ischemia-injury-induced neuronal cell death via the inhibition of iNOS/p38 MAPK and nitrotyrosine.

RatIschaemia-reperfusionCerebral (MCAO/stroke)Sprague-DawleyMaleIntraperitonealHericium erinaceus mycelium 50 and 300 mg/kg; erinacine A 1…90 minutes after the onset of ischaemia

Model: Global cerebral ischaemia and reperfusion by occlusion of the two common carotid arteries (stroke animal model)

Hericium erinaceus mycelium reduced total infarct volume by 22% at 50 mg/kg and 44% at 300 mg/kg relative to untreated stroke animals, and erinacine A dose dependently reduced infarct volume, inflammatory cytokines, nitrotyrosine, p38 MAPK phosphorylation and CHOP expression.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.